L-leucine is the potential metabolic biomarker of GT, is one of BCAA mainly involved in the pathway of valine, leucine and isoleucine biosynthesis and valine, leucine and isoleucine degradation, etc. BCAA have long been implicated in the etiology of type 2 diabetes. The gene discussed is ARID4B; the disease is type 2 diabetes mellitus.